These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21181985)

  • 1. The assessment of olivocochlear function in neonates with real-time distortion product otoacoustic emissions.
    James AL
    Laryngoscope; 2011 Jan; 121(1):202-13. PubMed ID: 21181985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient otoacoustic emissions in the detection of olivocochlear bundle maturation.
    Gkoritsa E; Tsakanikos M; Korres S; Dellagrammaticas H; Apostolopoulos N; Ferekidis E
    Int J Pediatr Otorhinolaryngol; 2006 Apr; 70(4):671-6. PubMed ID: 16198429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of medial olivocochlear system function in pre-term and full-term newborns using a rapid test of transient otoacoustic emissions.
    Morlet T; Hamburger A; Kuint J; Ari-Even Roth D; Gartner M; Muchnik C; Collet L; Hildesheimer M
    Clin Otolaryngol Allied Sci; 2004 Apr; 29(2):183-90. PubMed ID: 15113308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olivocochlear reflex effect on human distortion product otoacoustic emissions is largest at frequencies with distinct fine structure dips.
    Wagner W; Heppelmann G; Müller J; Janssen T; Zenner HP
    Hear Res; 2007 Jan; 223(1-2):83-92. PubMed ID: 17137736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for auditory neuropathy/auditory synaptopathy.
    Beutner D; Foerst A; Lang-Roth R; von Wedel H; Walger M
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):239-44. PubMed ID: 17409783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.
    Bolay H; Bayazit YA; Gündüz B; Ugur AK; Akçali D; Altunyay S; Ilica S; Babacan A
    Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of auditory brainstem responses and otoacoustic emissions in hearing screening of high-risk neonates].
    Xu FL; Xing QJ; Cheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):460-3. PubMed ID: 18706161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for auditory neuropathy spectrum disorder in a screened newborn population at risk for hearing loss.
    Bielecki I; Horbulewicz A; Wolan T
    Int J Pediatr Otorhinolaryngol; 2012 Nov; 76(11):1668-70. PubMed ID: 22939890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of hypoacusia secondary to hyperbilirubinaemia in a universal neonatal auditory screening programme based on otoacoustic emissions and evoked auditory potentials].
    Núñez-Batalla F; Carro-Fernández P; Antuña-León ME; González-Trelles T
    Acta Otorrinolaringol Esp; 2008 Mar; 59(3):108-13. PubMed ID: 18364202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous otoacoustic emissions and efferent control of cochlea].
    Xu J; Liu C; Guo L; Lian N; Liu B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):436-40. PubMed ID: 12761959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral suppression of linear and nonlinear transient evoked otoacoustic emissions in neonates at risk for hearing loss.
    Durante AS; Carvallo RM
    J Commun Disord; 2008; 41(1):70-83. PubMed ID: 17585930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audiologic evaluation of neonates with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses.
    Rhee CK; Park HM; Jang YJ
    Laryngoscope; 1999 Dec; 109(12):2005-8. PubMed ID: 10591364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
    Riga M; Korres S; Psarommatis I; Varvutsi M; Giotakis I; Papadas T; Ferekidis E; Apostolopoulos N
    Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of medial olivocochlear efferent activity in humans: comparison of different distortion product otoacoustic emission-based paradigms.
    Wagner W; Heyd A
    Otol Neurotol; 2011 Oct; 32(8):1379-88. PubMed ID: 21921859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of medial efferent auditory pathways.
    Veuillet E; Khalfa S; Collet L
    Scand Audiol Suppl; 1999; 51():53-62. PubMed ID: 10803914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol.
    Johnson JL; White KR; Widen JE; Gravel JS; James M; Kennalley T; Maxon AB; Spivak L; Sullivan-Mahoney M; Vohr BR; Weirather Y; Holstrum J
    Pediatrics; 2005 Sep; 116(3):663-72. PubMed ID: 16140706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Otoacoustic emissions. A futuristic objective hearing test].
    Plinkert PK
    Fortschr Med; 1993 Oct; 111(29):453-6. PubMed ID: 8258421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral suppression of distortion product otoacoustic emissions and the middle-ear muscle reflex in human ears.
    Sun XM
    Hear Res; 2008 Mar; 237(1-2):66-75. PubMed ID: 18258398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Auditory neuropathy].
    Liang F; Liu C; Liu B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 34(6):350-2. PubMed ID: 12764843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term sound conditioning increases distortion product otoacoustic emission amplitudes and decreases olivocochlear efferent reflex strength.
    Peng JH; Tao ZZ; Huang ZW
    Neuroreport; 2007 Jul; 18(11):1167-70. PubMed ID: 17589320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.